Clinical Trial Update: Addition of Azathioprine in IBD Patients With Immunogenic Failure [Phase 4]

View source ↗

Summary

Phase 4 study evaluating adding azathioprine to treatment in inflammatory bowel disease patients with immunogenic failure after switching therapies.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inflammatory Bowel Disease

Drugs mentioned

• Azathioprine (azathioprine)

Snippet

Sponsor: Védrines, Philippe, M.D. | Conditions: Clinical Failure After Switch | Phase 4 | Status: UNKNOWN